These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24435452)

  • 1. Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis.
    Liu Y; Sun MG; Jiang R; Ding R; Che Z; Chen YY; Yao CJ; Zhu XX; Cao JY
    J Assist Reprod Genet; 2014 Mar; 31(3):363-70. PubMed ID: 24435452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
    Lee YH; Song GG
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
    Lin S; Huiya Z; Bo L; Wei W; Yongmei G
    Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with polycystic ovary syndrome in Chinese patients: a meta-analysis.
    Wang LH; Wang LM; Zhou N
    Arch Gynecol Obstet; 2015 Sep; 292(3):683-6. PubMed ID: 25731152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.
    Diamanti-Kandarakis E; Palioniko G; Alexandraki K; Bergiele A; Koutsouba T; Bartzis M
    Eur J Endocrinol; 2004 Jun; 150(6):793-8. PubMed ID: 15191349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family-based analysis of -675 4G/5G polymorphism in the PAI-1 gene of polycystic ovary syndrome in Chinese population.
    Song X; Ge L; Wang D; Li L; Ma D; Li X; Song X
    J Obstet Gynaecol; 2022 Oct; 42(7):3304-3308. PubMed ID: 36065507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The -675 4G/5G polymorphism in the PAI-1 gene may not contribute to the risk of PCOS.
    Zhang TT; Yuan L; Yang YM; Ren Y
    Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2326-31. PubMed ID: 25219833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
    Sun L; Lv H; Wei W; Zhang D; Guan Y
    J Endocrinol Invest; 2010 Feb; 33(2):77-82. PubMed ID: 19636212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.
    Bagos PG
    Mol Hum Reprod; 2009 Jan; 15(1):19-26. PubMed ID: 19066200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
    Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
    Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polymorphism of the plasminogen activator inhibitor-1 gene promoter and the polycystic ovary syndrome.
    Walch K; Grimm C; Huber JC; Nagele F; Kolbus A; Hefler LA
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):77-81. PubMed ID: 16102886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome.
    Kilicci C; Bayram B; Ozkurt M; Onlu H; Erkasap N; Mutlu F
    Genet Test Mol Biomarkers; 2011; 15(7-8):565-7. PubMed ID: 21413876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reproductive problems in women with PCOS, the impact of PAL-1 CARRIERS OF 4G PAI -1 polymorphism and BMI].
    Komsa-Penkova R; Golemanov G; Georgieva G; Slavov N; Popovski K; Ivanov P; Kovacheva K; Atanasova M; Blajev A
    Akush Ginekol (Sofiia); 2014; 53(5):3-9. PubMed ID: 25558663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.
    Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M
    Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171
    [No Abstract]   [Full Text] [Related]  

  • 15. The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.
    Nie W; Li B; Xiu QY
    PLoS One; 2012; 7(3):e34385. PubMed ID: 22479620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.
    Li YY
    PLoS One; 2012; 7(4):e33511. PubMed ID: 22496752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reproductive problems in women with PCOS, the impact of PAI-1 carriers of 4G PAI-1 polymorphism and BMI].
    Komsa-Penkova R; Golemanov G; Georgieva G; Popovski K; Slavov N; Ivanov P; Kovacheva K; Atanasova M; Blajev A
    Akush Ginekol (Sofiia); 2014; 53(6):15-21. PubMed ID: 25672133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.
    Li X; Liu Y; Zhang R; Tan J; Chen L; Liu Y
    Med Sci Monit; 2015 Apr; 21():1051-6. PubMed ID: 25862335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis.
    Zhang X; Gao B; Xu B
    Medicine (Baltimore); 2020 Dec; 99(50):e23660. PubMed ID: 33327353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome.
    Sales MF; Sóter MO; Candido AL; Fernandes AP; Oliveira FR; Ferreira AC; Sousa MO; Ferreira CN; Gomes KB
    Gynecol Endocrinol; 2013 Oct; 29(10):936-9. PubMed ID: 23898913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.